ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorArtcline GmbH
About this trial
The objectives of this registry study are to:
1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.
Eligibility criteria
Qualifiers
Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their ICU stay
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov